Clinical Trial Update: Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV [Phase 2]

View source ↗

Summary

This update describes the completed Phase 2 safety and effectiveness study of a candidate vaginal microbicide intended to prevent HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Candidate vaginal microbicide (unidentified)

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: HIV Infections | Phase 2 | Status: COMPLETED